Keywords: Teijin Pharma, Ipsen, Somatuline, Japan, Acromegaly, Pituitary gigantism

Teijin and Ipsen's Somatuline cleared in Japan

Article | 01 July 2012

Japanese drugmaker Teijin Pharma (TYO: 3402) revealed last Friday that it has received manufacturing and marketing approval for Somatuline (lanreotide acetate) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Teijin

Ipsen

Go to company listing

Related Drugs

Somatuline

Go to drug listing